102 related articles for article (PubMed ID: 27376763)
1. Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.
Porcaro AB; Novella G; Cacciamani G; De Marchi D; Corsi P; De Luyk N; Bizzotto L; Processali T; Cerasuolo M; Tamanini I; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Urol Int; 2017; 98(1):22-27. PubMed ID: 27376763
[TBL] [Abstract][Full Text] [Related]
2. Prostate volume index stratified prostate cancer risk in patients elected to a first random biopsy set.
Porcaro AB; Corsi P; de Luyk N; Sebben M; Tafuri A; Bizzotto L; Cacciamani G; De Marchi D; Processali T; Mattevi D; Novella G; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Tumori; 2017 Jul; 103(4):374-379. PubMed ID: 28291903
[TBL] [Abstract][Full Text] [Related]
3. Prostate Volume Index Is Able to Differentiate between Prostatic Chronic Inflammation and Prostate Cancer in Patients with Normal Digital Rectal Examination and Prostate-Specific Antigen Values <10 ng/mL: Results of 564 Biopsy Naïve Cases.
Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Panunzio A; De Michele M; Brunelli M; Cerruto MA; Migliorini F; Siracusano S; Artibani W
Urol Int; 2019; 103(4):415-422. PubMed ID: 31466070
[TBL] [Abstract][Full Text] [Related]
4. Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer.
Porcaro AB; Novella G; Molinari A; Terrin A; Minja A; De Marco V; Martignoni G; Brunelli M; Cerruto MA; Curti P; Cavalleri S; Artibani W
Urol Int; 2015; 94(3):270-85. PubMed ID: 25170543
[TBL] [Abstract][Full Text] [Related]
5. Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set.
Porcaro AB; Novella G; de Luyk N; Corsi P; Cacciamani G; Sebben M; Tafuri A; Processali T; Cerasuolo M; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Tumori; 2017 Sep; 103(5):475-482. PubMed ID: 27834470
[TBL] [Abstract][Full Text] [Related]
6. Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy.
Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Mariotto A; Brunelli M; Cerruto MA; Cacciamani GE; Migliorini F; Siracusano S; Artibani W
World J Urol; 2020 Apr; 38(4):957-964. PubMed ID: 31154465
[TBL] [Abstract][Full Text] [Related]
7. [Relation of age and prostatic volume to cancer detection in prostatic biopsies from patients with non-suspect rectal palpation].
Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Subira Ríos D; Castaño González I; Moralejo Gárate M; Martínez Salamanca JI; Cabello Benavente R
Arch Esp Urol; 2003 May; 56(4):359-66. PubMed ID: 12830608
[TBL] [Abstract][Full Text] [Related]
8. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population.
Wang Y; Xie S; Shangguan X; Pan J; Zhu Y; Xin Z; Xu F; Shao X; Fan L; Sha J; Liu Q; Dong B; Xue W
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1157-1166. PubMed ID: 28283782
[TBL] [Abstract][Full Text] [Related]
9. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy.
Scattoni V; Raber M; Abdollah F; Roscigno M; Dehò F; Angiolilli D; Maccagnano C; Gallina A; Capitanio U; Freschi M; Doglioni C; Rigatti P; Montorsi F
Eur Urol; 2010 Jan; 57(1):1-8. PubMed ID: 19720449
[TBL] [Abstract][Full Text] [Related]
10. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
11. Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients.
Porcaro AB; Tafuri A; Sebben M; Novella G; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Shakir A; Brunelli M; Cerruto MA; Migliorini F; Siracusano S; Artibani W
Int Braz J Urol; 2020; 46(4):545-556. PubMed ID: 32213210
[TBL] [Abstract][Full Text] [Related]
12. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
13. Inverse Association of Prostatic Chronic Inflammation among Prostate Cancer Tumor Grade Groups: Retrospective Study of 738 Consecutive Cases Elected to a First Random Biopsy Set.
Porcaro AB; Tafuri A; Novella G; Sebben M; Mariotto A; Inverardi D; Corsi P; Processali T; Pirozzi M; Amigoni N; Rizzetto R; Brunelli M; Balzarro M; Siracusano S; Artibani W
Urol Int; 2018; 100(4):456-462. PubMed ID: 29672311
[TBL] [Abstract][Full Text] [Related]
14. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter.
Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK
Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070
[TBL] [Abstract][Full Text] [Related]
15. Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (≥ 12)-core prostate biopsy.
Hong SK; Oh JJ; Byun SS; Hwang SI; Lee HJ; Choe G; Lee SE
Prostate; 2012 Jan; 72(1):51-7. PubMed ID: 21520162
[TBL] [Abstract][Full Text] [Related]
16. Larger men have larger prostates: Detection bias in epidemiologic studies of obesity and prostate cancer risk.
Rundle A; Wang Y; Sadasivan S; Chitale DA; Gupta NS; Tang D; Rybicki BA
Prostate; 2017 Jun; 77(9):949-954. PubMed ID: 28349547
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of the prostate health index versus the urinary prostate cancer antigen 3 score to predict overall and significant prostate cancer at initial biopsy.
Seisen T; Rouprêt M; Brault D; Léon P; Cancel-Tassin G; Compérat E; Renard-Penna R; Mozer P; Guechot J; Cussenot O
Prostate; 2015 Jan; 75(1):103-11. PubMed ID: 25327361
[TBL] [Abstract][Full Text] [Related]
18. Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information.
Zaytoun OM; Kattan MW; Moussa AS; Li J; Yu C; Jones JS
Urology; 2011 Aug; 78(2):392-8. PubMed ID: 21705045
[TBL] [Abstract][Full Text] [Related]
19. The potential impact of prostate volume in the planning of optimal number of cores in the systematic transperineal prostate biopsy.
Ficarra V; Novella G; Novara G; Galfano A; Pea M; Martignoni G; Artibani W
Eur Urol; 2005 Dec; 48(6):932-7. PubMed ID: 16202510
[TBL] [Abstract][Full Text] [Related]
20. The optimal number of initial prostate biopsy cores in daily practice: a prospective study using the Nara Urological Research and Treatment Group nomogram.
Tanaka N; Shimada K; Nakagawa Y; Hirao S; Watanabe S; Miyake M; Anai S; Hirayama A; Konishi N; Fujimoto K
BMC Res Notes; 2015 Nov; 8():689. PubMed ID: 26581414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
